Evidence map›Paper›PMID 37609169›Full record

ArticlebioRxiv : the preprint server for biology2024

Transcutaneous cervical vagus nerve stimulation improves sensory performance in humans.

Michael Jigo, Jason B Carmel, Qi Wang, Charles Rodenkirch

Open access · greenAbstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

Michael JigoSharper Sense, Inc., New York, NY.ORCID 0000-0002-9742-4576
Jason B CarmelSharper Sense, Inc., New York, NY.ORCID 0000-0002-3933-3692
Qi WangSharper Sense, Inc., New York, NY.ORCID 0000-0001-8656-1439
Charles RodenkirchSharper Sense, Inc., New York, NY.ORCID 0000-0002-8255-6699
Columbia University · USColumbia University Irving Medical Center · USCornell University · US

Funding

The effects of long-term locus coeruleus stimulation on amyloid/tau pathology, synaptic plasticity, and memory during Alzheimer's disease progressionR01AG075114 · NIA · COLUMBIA UNIV NEW YORK MORNINGSIDE · PI Qi Wang · 2022 to 2026
$2.4M
Noradrenergic and Cholinergic Mechanisms Underlying Pupil-Linked Arousal Modulation of Thalamic Sensory ProcessingR01NS119813 · NINDS · COLUMBIA UNIV NEW YORK MORNINGSIDE · PI WANG, QI · 2021 to 2025
$2.2M
Cholinergic contribution to pupil-linked arousalR21MH125107 · NIMH · COLUMBIA UNIV NEW YORK MORNINGSIDE · PI WANG, QI · 2021 to 2022
$446k
NIA NIH HHS R01 AG075114NIMH NIH HHS R21 MH125107NINDS NIH HHS R01 NS119813
6 · The paper itself

Abstract

Accurate senses depend on high-fidelity encoding by sensory receptors and error-free processing in the brain. Progress has been made towards restoring damaged sensory receptors. However, methods for on-demand treatment of impaired central sensory processing are scarce. Prior invasive studies demonstrated that continuous vagus nerve stimulation (VNS) in rodents can activate the locus coeruleus-norepinephrine system to rapidly improve central sensory processing. Here, we investigated whether transcutaneous VNS improves sensory performance in humans. We conducted three sham-controlled experiments, each with 12 neurotypical adults, that measured the effects of transcutaneous VNS on metrics of auditory and visual performance, and heart rate variability (HRV). Continuous stimulation was delivered to cervical (tcVNS) or auricular (taVNS) branches of the vagus nerve while participants performed psychophysics tasks or passively viewed a display. Relative to sham stimulation, tcVNS improved auditory performance by 37% (p=0.00052) and visual performance by 23% (p=0.038). Participants with lower performance during sham conditions experienced larger tcVNS-evoked improvements (p=0.0040). Lastly, tcVNS increased HRV during passive viewing, corroborating vagal engagement. No evidence for an effect of taVNS was observed. These findings validate the effectiveness of tcVNS in humans and position it as a method for on-demand interventions of impairments associated with central sensory processing dysfunction.

Identifiers

PMID37609169
PMCPMC10441305
OpenAlexW4385786676

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.